Eliquis Supplemental New drug application,sNDA has been approved by the US FDA for treatment of DVT and PE(Blood clots ) and for reduction of risk of Recurrent DVT and PE after initial treatment(therapy)
DVT is blood clot in vein,generally in lower leg or thigh or pelvis which causes partial or complete halt of blood flow in these regions.PE is blood clot in one or more LUNG vessels ,blocking them.DVT progresses to PE if left untreated. DVT and PE together are called VTE.
Eliquis ,(Apixaban) is an oral selective Factor Xa inhibitor,an important blood clotting protein.By inhibiting this it decreases blood clot formation.
DVT is blood clot in vein,generally in lower leg or thigh or pelvis which causes partial or complete halt of blood flow in these regions.PE is blood clot in one or more LUNG vessels ,blocking them.DVT progresses to PE if left untreated. DVT and PE together are called VTE.
Eliquis ,(Apixaban) is an oral selective Factor Xa inhibitor,an important blood clotting protein.By inhibiting this it decreases blood clot formation.